Intravenous Catheters Market Size - By Product Type (Midline Peripheral, PICC, CVC), Gauge Size (14G–16G, 17G–18G, 19G–20G, 21G–22G, 23G+), Lumen (Single, Double, Multi-Lumen), Material (Polyurethane, Silicone, PVC), End-use & Global Forecast, (2024 – 2032)

Intravenous Catheters Market Size

Intravenous Catheters Market size was valued at USD 9.4 billion in 2023 and is expected to grow a CAGR of 7.8% between 2024 and 2032. This high market growth can be primarily attributed to numerous factors including patient preference for minimally invasive procedures, rise in ambulatory care centers, increasing focus on home healthcare, rising geriatric population and growing surgical procedures across the globe.
 

An increasing prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and cancer, necessitates the frequent use of intravenous catheters for administration of medications and fluids. For instance, as per the data reported by Centers for Disease Control and Prevention (CDC), around 805,000 people suffer from heart attack every year in the U.S.
 

Additionally, 1 in every 5 persons in the U.S. or around 695,000 people died from heart diseases in 2021. Hence, the increasing number of patients experiencing various chronic disorders, coupled with supportive government initiatives, will drive the demand for the product. Moreover, favorable regulatory environments that encourage innovation and ensure product safety contribute to the growth of the intravenous catheters market.
 

Intravenous catheter is a tiny, flexible tube inserted into a peripheral vein that enables the administration of a broad spectrum of therapeutics including medicines and fluids directly into the bloodstream.
 

Intravenous Catheters Market Trends

Incorporation of smart technologies into catheters to monitor various parameters in real-time including sensors that can track factors such as catheter tip position, blood flow rates, and the presence of air bubbles, provides healthcare professionals with crucial data for better patient management. All such variables make intravenous catheterization safer, more efficient, and more patient friendly.
 

• Using nanotechnology to develop catheter materials with enhanced biocompatibility and reduced thrombogenicity. Nanoscale modifications can improve the surface properties of the catheter, potentially decreasing the risk of clot formation.
   
• Integration of antimicrobial coatings on catheters to reduce the risk of infection. These coatings can inhibit the growth of bacteria on the catheter's surface, lowering the incidence of catheter-related infections.
   
• Moreover, use of ultrasound technology for guided catheter insertion improves the accuracy of catheter placement, reduces the likelihood of complications, and enhances the overall success rate of the procedure.
   

Intravenous Catheters Market Analysis

The intravenous catheters industry by product type is categorized into midline peripheral catheter, peripherally inserted central catheter, and central venous catheter. The peripherally inserted central catheter segment held over USD 5.4 billion revenue in 2023.
 

• The versatility of PICCs makes them suitable for outpatient and homecare settings. The insertion of PICCs is generally less traumatic for patients compared to other central venous catheters. The catheter is typically inserted in the arm, avoiding sensitive areas like the neck or chest, which can improve patient comfort. Patients can receive intravenous therapy at home, which can enhance their quality of life and reduce the burden on healthcare facilities.
   
• Additionally, compared to traditional central venous catheters, PICCs have a lower risk of infection and other complications. Their insertion is typically less invasive, leading to a reduced risk of pneumothorax and other associated issues.
   
• Further, advances in medical imaging technologies, such as ultrasound guidance during catheter insertion, enhance the accuracy and safety of the procedure, making PICCs a more attractive option.

Based on gauge size, the intravenous catheters market is segmented into 14G – 16G, 17G – 18G, 19G – 20G, 21G – 22G, and 23G+. The 21G – 22G segment is anticipated to reach USD 5.9 billion by 2032.
 

• Catheters in the 21 – 22 gauge range are commonly used for routine IV infusions in both adults and pediatric patients. They provide a balanced compromise between flow rate and patient comfort. These catheters are suitable for administering medications that do not require a rapid flow rate. They are commonly used for a variety of medications in different healthcare settings.
   
• In pediatric patients, who often have smaller veins, 21 – 22 gauge catheters may be preferred to minimize discomfort and potential complications.
   
• Furthermore, for short-term intravenous therapy that does not require a large volume or rapid infusion, healthcare professionals may choose catheters in the 21 – 22 gauge range.
   

The intravenous catheters market by lumen is categorized into single lumen, double lumen, and multi-lumen. The single lumen segment accounted for USD 3.8 billion revenue size in 2023.
 

• Single-lumen catheters are frequently employed for routine intravenous infusions in hospitals, clinics, and outpatient settings. They provide a simple and effective means of delivering fluids, medications, or nutrients directly into the patient's bloodstream.
   
• Moreover, in situations where a patient requires a single medication, single-lumen catheters are commonly chosen for medication administration. This can include antibiotics, pain medications, and other intravenous drugs. For blood transfusions where only one type of blood product needs to be administered, single-lumen catheters are often utilized.
   
• Single-lumen catheters are commonly employed in pediatric patients, where the volume of fluid or medication needed may be smaller, and a single lumen is sufficient.
   

Based on material, the intravenous catheters market is segmented into polyurethane, silicone, PVC, and other materials. The silicone segment is expected to expand at a CAGR of 8.1% during the forecast period.
 

• Silicone is known for its biocompatibility, which means it is generally well-tolerated by the body. This property can be advantageous in reducing the risk of irritation or allergic reactions. Also, silicone catheters are often soft and flexible, making them more comfortable for patients. This characteristic can be particularly beneficial in situations where long-term catheterization is required.
   
• Silicone catheters have a higher resistance to kinking compared to other materials, contributing to the stability of the catheter during use. The softness and durability of silicone may make it a suitable choice for catheters intended for long-term use.
   

The intravenous catheters market by end-use is categorized into hospitals, ambulatory surgical centers, and other end-users. The hospitals segment recorded around USD 5.2 billion revenue size in 2023.
 

• Intravenous catheters are commonly used during surgical procedures to administer anesthesia, antibiotics, and other medications, as well as to provide intravenous fluids. IV catheters play a vital role in postoperative care by facilitating the administration of pain medications, fluids, and other necessary treatments. Majority of the surgical procedures are performed in hospital settings, thus due to increased product demand the segment is anticipated to witness robust growth.
   
• Intravenous catheters are crucial for administering blood transfusions in hospital settings, particularly in surgical and critical care units.
   
• Moreover, hospitals use intravenous catheters to provide parenteral nutrition to patients who are unable to receive adequate nutrition through oral or enteral routes.

North America intravenous catheters market size reached USD 3.1 billion in 2023 and is set to witness substantial industry growth over the analysis timeline.
 

• The trend toward home healthcare services in North America has led to increased demand for intravenous catheters suitable for use in a home setting. Patients receiving intravenous therapies at home may require distinct types of catheters.
   
• Additionally, the rise of ambulatory care centers and outpatient clinics also contributes to the demand for intravenous catheters. These settings often require catheters for a range of medical procedures and treatments. For example, according to a recently published article by Sg2, a Vizient company in its “2023 Impact of Change Forecast” stated that ambulatory surgery centers (ASCs) are expected to record double-digit growth over the next decade.
   
• Further, emphasis on patient safety and the reduction of healthcare-associated infections has led to the development and adoption of catheters with features such as antimicrobial coatings, potentially influencing demand. Such developments will further fuel the product demand in the region.
   

Intravenous Catheters Market Share

The intravenous catheters industry is competitive in nature, with various large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products with improved efficiency and cost-effectiveness is among a key market strategy for catheter manufacturers. Some of the leading industry players including Becton, Dickinson and Company, B. Braun Melsungen AG, Boston Scientific Corporation, Medtronic plc, and Teleflex Incorporated, among others have a substantial presence in the market.
 

Intravenous Catheters Market Companies

Some of the eminent market participants operating in the intravenous catheters industry include:

• AngioDynamics, Inc.
• Argon Medical Devices
• Becton, Dickinson and Company
• B. Braun Melsungen AG
• Boston Scientific Corporation
• Hamilton Company
• ICU Medical, Inc.
• Medilivescare Manufacturing Pvt. Ltd.
• Medtronic plc
• Nipro Corporation
• Poly Medicure Ltd.
• Teleflex Incorporated
• Terumo Corporation
• Vygon
   

Intravenous Catheters Industry News:

• In November 2023, Becton, Dickinson and Company, launched its new needle-free blood draw technology that is compatible with integrated catheters and long peripheral IV catheters. This latest development in company's PIVO portfolio will allow the company to expand its product portfolio and reach to more patients.
   
• In July 2022, B. Braun Medical Inc., a key player in global infusion therapy, launched its new Introcan Safety 2 IV Catheter with one-time blood control feature. This development will aid in reducing the risk of needlestick injuries for the clinicians.
   

The intravenous catheters market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million and volume (units) from 2018 to 2032, for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Midline peripheral catheter
• Peripherally inserted central catheter
• Central venous catheter

Market, By Gauge Size

• 14G – 16G
• 17G – 18G
• 19G – 20G
• 21G – 22G
• 23G+

Market, By Lumen

• Single lumen
• Double lumen
• Multi-lumen

Market, By Material

• Polyurethane
• Silicone
• PVC
• Other materials

Market, By End-use

• Hospitals
• Ambulatory surgical centers
• Other end-users

The above information has been provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa